Skip to content
  • Data Privacy and Policies
  • Careers
  • News & Events
    • Press Releases
    • In the News
    • LinkedIn Feed
    • Meet Us At….
  • Contact
  • Data Privacy and Policies
  • Careers
  • News & Events
    • Press Releases
    • In the News
    • LinkedIn Feed
    • Meet Us At….
  • Contact
Rinri Therapeutics
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Hearing Loss
    • Hearing Loss
    • The impact
  • Our Approach and Portfolio
    • Overview
    • Our approach to hearing restoration
    • Our hearing restoration product portfolio
    • Conversations
  • Our Clinical Research
    • The First in Human trial of Rincell-1
    • Objective Measures of Neural Health
    • Frequently Asked Questions
  • Patient & Clinicians
    • Patients as partners
    • Working with clinicians
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Hearing Loss
    • Hearing Loss
    • The impact
  • Our Approach and Portfolio
    • Overview
    • Our approach to hearing restoration
    • Our hearing restoration product portfolio
    • Conversations
  • Our Clinical Research
    • The First in Human trial of Rincell-1
    • Objective Measures of Neural Health
    • Frequently Asked Questions
  • Patient & Clinicians
    • Patients as partners
    • Working with clinicians
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Hearing Loss
    • Hearing Loss
    • The impact
  • Our Approach and Portfolio
    • Overview
    • Our approach to hearing restoration
    • Our hearing restoration product portfolio
    • Conversations
  • Our Clinical Research
    • The First in Human trial of Rincell-1
    • Objective Measures of Neural Health
    • Frequently Asked Questions
  • Patient & Clinicians
    • Patients as partners
    • Working with clinicians
  • News & Events
    • Press Releases
    • In the News
    • LinkedIn Feed
    • Meet Us At….
  • Data Privacy and Policies
  • Careers
  • Contact
Rinri Therapeutics
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Hearing Loss
    • Hearing Loss
    • The impact
  • Our Approach and Portfolio
    • Overview
    • Our approach to hearing restoration
    • Our hearing restoration product portfolio
    • Conversations
  • Our Clinical Research
    • The First in Human trial of Rincell-1
    • Objective Measures of Neural Health
    • Frequently Asked Questions
  • Patient & Clinicians
    • Patients as partners
    • Working with clinicians
  • News & Events
    • Press Releases
    • In the News
    • LinkedIn Feed
    • Meet Us At….
  • Data Privacy and Policies
  • Careers
  • Contact
Rinri Therapeutics
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Hearing Loss
    • Hearing Loss
    • The impact
  • Our Approach and Portfolio
    • Overview
    • Our approach to hearing restoration
    • Our hearing restoration product portfolio
    • Conversations
  • Our Clinical Research
    • The First in Human trial of Rincell-1
    • Objective Measures of Neural Health
    • Frequently Asked Questions
  • Patient & Clinicians
    • Patients as partners
    • Working with clinicians
  • News & Events
    • Press Releases
    • In the News
    • LinkedIn Feed
    • Meet Us At….
  • Data Privacy and Policies
  • Careers
  • Contact

The Therapeutic Areas Evolving Through Cell and Gene Therapy Innovation

rinri-therapeutics2026-04-10T16:49:33+00:00

Get in touch

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.

Rinri Therapeutics Ltd.
Innovation Centre
217 Portobello
Sheffield S1 4DP

Tel. +44 [0] 114 222 4330
Email. enquiries@rinri-therapeutics.com

Legal

Terms and Conditions
Data Privacy and Policies
Cookie Policy

© Rinri Therapeutics Ltd. All Rights Reserved. Registered number 08839972

Page load link
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Go to Top